Loading...

Categories

11 Brazil Diabetes Care Drugs Reports

Diabetes Care Drugs Market

Country Covered: Brazil

Study Period: 2019 - 2029

Major Players: Novo Nordisk, Sanofi, AstraZeneca, Boehringer Ingelheim, Eli Lilly and Company

Brazil Diabetes Drugs Industry

Country Covered: Brazil

Study Period: 2018 - 2029

Major Players: AstraZeneca, MSD, Boehringer Ingelheim, Novo Nordisk A/S, Sanofi Aventis

Brazil Oral Anti-Diabetic Drug Market

Country Covered: Brazil

Study Period: 2019 - 2029

Major Players: Astrazeneca, Astellas, Janssen, Eli Lilly, Sanofi

Diabetes Drugs in Latin America Industry

Country Covered: Brazil

Study Period: 2019 - 2029

Major Players: Novo Nordisk, Sanofi, Eli Lilly, AstraZeneca, Boehringer Ingelheim

Latin America Oral Anti-Diabetic Drug Market

Country Covered: Brazil

Study Period: 2019 - 2029

Major Players: Sanofi, Astellas, Astrazeneca, Eli Lilly, Janssen Pharmaceuticals

Anti Obesity Drugs Industry

Country Covered: Brazil

Study Period: 2019 - 2029

Major Players: Vivus, F Hoffmann-La Roche AG, GlaxoSmithKline PLC, Novo Nordisk AS, Currax Pharmaceuticals LLC

Diabetic Foot Ulcer Treatment Market

Country Covered: Brazil

Study Period: 2019 - 2029

Major Players: Convatec Inc., 3M, Integra LifeSciences, Coloplast Corp, Cardinal Health

Proliferative Diabetic Retinopathy Market

Country Covered: Brazil

Study Period: 2019 - 2029

Major Players: Novartis AG, Regeneron Pharmaceuticals Inc, Allergan Plc, Hoffmann-La Roche (Genentech), Oxurion NV

Diabetes Combination Drugs Market

Country Covered: Brazil

Study Period: 2019- 2029

Major Players: Boehringer Ingelheim, Sanofi Aventis, Merck & Co., Inc., Eli Lilly and Company, Novo Nordisk A/S

Oral Antidiabetic Drugs Market

Country Covered: Brazil

Study Period: 2018 - 2029

Major Players: Eli Lilly and Company, Astellas Pharma Inc., Sanofi S.A., Janssen Pharmaceuticals, AstraZeneca

Hyperlipidemia Drugs Industry

Country Covered: Brazil

Study Period: 2019 - 2029

Major Players: Merck & Co., Inc, Sanofi, Amgen, AstraZeneca, Viatris Inc.